MedTrace Logo

Evaluation of MDW for Early Detection of Sepsis, Clinical Validity

NCT03588325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 947

Last updated 2019-11-22

No results posted yet for this study

Summary

The purpose of this study is to confirm the clinical validity and the performance of the Monocyte Width Distribution (MDW) parameter to detect the development of sepsis in a prospective study of Emergency Department (ED) adults who have blood draw including Complete Blood Count with differential (CBC-DIFF) ordered upon presentation in a Spanish \& French hospital and to verify cut-off for Tri-potassium ethylenediaminetetraacetic acid (K3EDTA).

Conditions

  • Severe Infection
  • Sepsis
  • Severe Sepsis

Interventions

DIAGNOSTIC_TEST

CBC-DIFF with MDW, PCT, CRP

Tests will be run to determine early identification of sepsis and added value of the combination of tests. Results will not be used to manage patients

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Principal Investigators

  • Pierre Hausfater, MD · Groupe Hospitalier Pitié-Salpêtrière

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-08
Primary Completion
2019-08-02
Completion
2019-08-30

Countries

  • France
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03588325 on ClinicalTrials.gov